Rheumatologe

Blog von Dr. med. Lothar M. Kirsch / 祁建德 // Poetry / Travels / Languages / Rheumatic Diseases / Tea

Seiten / Pages

▼
Showing posts with label PKI. Show all posts
Showing posts with label PKI. Show all posts
Wednesday, May 31, 2017

High Hopes and Aspirations or how ASP015K / Peficitinib brings back the Small Molecule Hype

›
ASP015K, now called peficitinib is an oral Janus kinase (JAK) inhibitor with selectivity for JAK1/3, developed by Astellas Pharma...
Saturday, November 19, 2016

Otezla® and an increased risk of suicide

›
Otezla® (active ingredient: Apremilast from Celgene) has been given a "Red Hand Letter" this month. In a "red hand let...

Otezla® und ein erhöhtes Risiko für Selbstmord

›
Zu Otezla® (Wirkstoff: Apremilast der Firma Celgene) hat es diesen Monat einen „Rote Hand Brief“ gegeben. In einem „Rote Hand Brief“ bekomme...
Friday, November 11, 2016

Baricitinib reaching out for the market

›
It seems that baricitinib gets ready to come to the market. The annual meetings this year have seen a plethora of studies on baricitini...
›
Home
View web version

Über mich / About myself / 自己的介绍

Rheumatologe
View my complete profile
Powered by Blogger.